RxNorm 1490033

droxidopa 200 MG

RxNorm Semantic Concepts

RxNorm semantic concepts for the RxCUI 1490033 unique identifier include: droxidopa 200 MG (12284472).

RxNorm Atom ID: 12284472 - Semantic Clinical Drug Component
droxidopa 200 MG

RXCUI:
1490033 - RxNorm Unique Identifier for a concept (Concept ID)
LAT:
ENG - Language of the Term
RXAUI:
12284472 - Unique identifier for the atom (RxNorm Atom ID)
Is Prescribable?
YES - This drug is part of the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States. The Current Prescribable subset also includes over-the-counter drugs.
Concept Description:
droxidopa 200 MG - Description of concept identifier
Term Type (TTY):
SCDC - Term type in source with name and description
Term Type Name:
Semantic Clinical Drug Component - Name of term type in source
Term Type Description:
Ingredient + Strength - Description of term type in source
Code:
1490033 - "Most useful" source asserted identifier. If the source vocabulary has more than one identifier, or a RxNorm-generated source entry identifier. (if the source vocabulary has none.)
Suppress Flag:
N
Suppressible flag. Values = N, O, Y, or E. N - not suppressible. O - Specific individual names (atoms) set as Obsolete because the name is no longer provided by the original source. Y - Suppressed by RxNorm editor. E - unquantified, non-prescribable drug with related quantified, prescribable drugs. NLM strongly recommends that users not alter editor-assigned suppressibility.
CVF:
4096 - Content view flag. RxNorm includes one value, '4096', to denote inclusion in the Current Prescribable Content subset. All rows with CVF='4096' can be found in the subset.
Source:
RXNORM - Concept source abbreviation
Source Name:
RxNorm Vocabulary - The official name for a source
Source Version:
20AA_240401F - The source version
Source Date:
March 04, 2024 - RxNorm data last updated
Source License Contact:
RxNorm Customer Service

U.S. National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
(888) FIND-NLM

[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/ - The source license contact information
Source Content Contact:
RxNorm Customer Service

U.S. National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
(888) FIND-NLM

[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/ - The source content contact information
Source Short Name:
RxNorm work done by the National Library of Medicine - The short name of a source as used by the NLM Knowledge Source Server

RxNorm Atom 12284472 Attributes

PropertyValueExplanation
RXN BOSS STRENGTH DENOM UNIT1RXN Boss Strength Denom Unit
RXN BOSS STRENGTH DENOM VALUE1RXN Boss Strength Denom Value
RXN BOSS STRENGTH NUM UNITMGRXN Boss Strength Num Unit
RXN BOSS STRENGTH NUM VALUE200RXN Boss Strength Num Value
RXN STRENGTH200 MGStrength plus unit of SCDC

* This product uses publicly available data courtesy of the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Patient Education

Droxidopa


Droxidopa is used to treat symptoms (dizziness, lightheadedness, or a fainting sensation [feeling that you are about to black out]) of neurogenic orthostatic hypotension (a sudden fall in blood pressure that occurs when a person assumes a standing position caused by certain nervous system conditions). Droxidopa is in a class of medications called alpha and beta-adrenergic agonists. It works by increasing the levels of norepinephrine, a natural substance in the body.
[Learn More]


* Please review the disclaimer below.